检索结果 - Valsamo Anagnostou

Refine Results
  1. 1
    Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention

    Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention 由 Valsamo Anagnostou, Victor E. Velculescu

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    MECHANISMS IN ENDOCRINOLOGY: Primary HT and risk for breast cancer: a systematic review and meta-analysis

    MECHANISMS IN ENDOCRINOLOGY: Primary HT and risk for breast cancer: a systematic review and meta-analysis 由 Anna Angelousi, Valsamo Anagnostou, Michael Stamatakos, Georgios Georgiopoulos, Konstantinos Kontzoglou

    出版 2011
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma

    Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma 由 Valsamo Anagnostou, Konstantinos N. Syrigos, Gerold Bepler, Robert Homer, David L. Rimm

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy

    Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy 由 Valsamo Anagnostou, Blair V. Landon, Jamie E. Medina, Patrick M. Forde, Victor E. Velculescu

    出版 2022
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Evaluation of machine learning methods to predict peptide binding to MHC Class I proteins

    Evaluation of machine learning methods to predict peptide binding to MHC Class I proteins 由 Rohit Bhattacharya, Ashok Sivakumar, Collin Tokheim, Violeta Beleva Guthrie, Valsamo Anagnostou, Victor E. Velculescu, Rachel Karchin

    出版 2017
    获取全文 获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  6. 6
    Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity

    Deep neural networks predict class I major histocompatibility complex epitope presentation and transfer learn neoepitope immunogenicity 由 Benjamin Alexander Albert, Yunxiao Yang, Xiaoshan M. Shao, Dipika Singh, Kellie N. Smith, Valsamo Anagnostou, Rachel Karchin

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Antibody validation

    Antibody validation 由 Jennifer Bordeaux, Allison W. Welsh, Seema Agarwal, Elizabeth Killiam, Maria T. Baquero, Jason A. Hanna, Valsamo Anagnostou, David L. Rimm

    出版 2010
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Analytic Variability in Immunohistochemistry Biomarker Studies

    Analytic Variability in Immunohistochemistry Biomarker Studies 由 Valsamo Anagnostou, Allison Welsh, Jennifer M. Giltnane, Summar Siddiqui, Camil Liceaga, Mark Gustavson, Konstantinos N. Syrigos, Jill L. Reiter, David L. Rimm

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity

    Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity 由 Valsamo Anagnostou, Mark Yarchoan, Aaron R. Hansen, Hao Wang, Franco Verde, Elad Sharon, Deborah Collyar, Laura Q.M. Chow, Patrick M. Forde

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time

    Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time 由 Maria Vassilakopoulou, Fabio Parisi, Summar Siddiqui, Allison England, Elizabeth R Zarella, Valsamo Anagnostou, Yuval Kluger, David G. Hicks, David L. Rimm, Veronique Neumeister

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Programmed death ligand-1 expression in non-small cell lung cancer

    Programmed death ligand-1 expression in non-small cell lung cancer 由 Vamsidhar Velcheti, Kurt A. Schalper, Daniel Carvajal, Valsamo Anagnostou, Konstantinos N. Syrigos, Mario Sznol, Roy S. Herbst, Scott Gettinger, Lieping Chen, David L. Rimm

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues

    Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues 由 V. M. Neumeister, Valsamo Anagnostou, Shahla Siddiqui, Allison England, Elizabeth Zarrella, Maria Vassilakopoulou, Francesco Parisi, Yuval Kluger, D. G. Hicks, David L. Rimm

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy

    Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy 由 Lavanya Sivapalan, Joseph C. Murray, Jenna VanLiere Canzoniero, Blair V. Landon, Jennifer Jackson, Susan C. Scott, Vincent K. Lam, Benjamin Levy, Mark Sausen, Valsamo Anagnostou

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy

    A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy 由 Thomas U. Marron, Jason J. Luke, Brianna Hoffner, Jane Perlmutter, Connie M. Szczepanek, Valsamo Anagnostou, Ann W. Silk, Pedro Romero, Elizabeth Garrett–Mayer, Leisha A. Emens

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells

    Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells 由 Christopher R. Zito, Lucia B. Jilaveanu, Valsamo Anagnostou, David L. Rimm, Gerold Bepler, Sauveur-Michel Maira, Wolfgang Hackl, Robert L. Camp, Harriet M. Kluger, Herta H. Chao

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis

    Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis 由 Elise Gray-Gaillard, Ami A. Shah, Clifton O. Bingham, Jennifer H. Elisseeff, Joseph C. Murray, Julie R. Brahmer, Patrick M. Forde, Valsamo Anagnostou, Jennifer S. Mammen, Laura C. Cappelli

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study

    Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study 由 C. Kent Osborne, Patrick Neven, Luc Dirix, John R. Mackey, Jean Robert, Craig Underhill, Rachel Schiff, Carolina Gutiérrez, Ilenia Migliaccio, Valsamo Anagnostou, David L. Rimm, Patrick Magill, Mark Sellers

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue

    A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue 由 Veronique Neumeister, Fabio Parisi, Allison England, Summar Siddiqui, Valsamo Anagnostou, Elizabeth Zarrella, Maria Vassilakopolou, Yalai Bai, Sasha Saylor, Anna Sapino, Yuval Kluger, David G. Hicks, Gianni Bussolati, Stephanie Kwei, David L. Rimm

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets

    High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets 由 Xiaoshan M. Shao, Rohit Bhattacharya, Justin Huang, I.K. Ashok Sivakumar, Collin Tokheim, Lily Zheng, Dylan Hirsch, Benjamin Kaminow, Ashton Omdahl, Maria Bonsack, Angelika B. Riemer, Victor E. Velculescu, Valsamo Anagnostou, Kymberleigh A. Pagel, Rachel Karchin

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

    HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients 由 Joonho Shim, H.S. Kim, Hongui Cha, Soo‐Chan Kim, T.M. Kim, Valsamo Anagnostou, Yoon‐La Choi, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, K. Park, W.-Y. Park, S.-H. Lee

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: